CRANBURY, N.J.--(BUSINESS WIRE)--Jul 11, 2019--

LC GC ®, a leading multimedia platform of peer-reviewed technical information on the field of chromatography and the separation sciences, and BioPharm International ® , a digital resource of technical articles, technology reports, regulatory and business columns, and expert commentary surrounding biopharmaceuticals, biotechnology and bioprocessing, will host the webcast, “Improving Confidence and Productivity in Released Glycan Analysis for Biotherapeutic Development,” on Wednesday, July 17, at 11 a.m. EDT.

“This webcast is part two of a three-part series introducing the Waters BioAccord LC-MS System, the first SmartMSTM-Enabled Biopharma Solution,” said Tom Ehardt, president of MultiMedia Healthcare, LLC. “We look forward to hosting this informational webcast with Waters software expert, Dr. Zhang.”

Senior scientist in the Biopharmaceutical Group of Scientific Operations at Waters Corporation, Ximo Zhang, PhD, will discuss workflows developed on the compact and integrated LC-MS System, how to improve productivity and reproducibility with automated sample preparation and present case studies demonstrating how simplified analytical workflow transforms high-quality LC/FLR/MS data into meaningful results for released N-glycan analysis.

To learn more and to register, click here.

About LC GC®

LC GC® is the largest global chromatography multimedia platform dedicated to the separation sciences. Combining all the resources of the regional editions ( LC GC North America, LC GCEurope and LC GC Asia-Pacific ), chromatographyonline.com is the premier global digital resource for unbiased, peer-reviewed technical information on the field of chromatography and the separation sciences. LC GC® delivers practical information that can help lab professionals become more proficient in the use of chromatographic techniques and instrumentation, thereby making laboratories more productive and businesses around the world more successful. LC GC® is part of MultiMedia Healthcare, LLC.

About BioPharm International®

BioPharm International® integrates the science and business of biopharmaceutical research, development and manufacturing. BioPharm International® is a multimedia peer-reviewed resource on technical solutions to help biopharmaceutical professionals succeed in their work. This digital platform features peer-reviewed papers, technical articles, technology reports, regulatory and business columns, and expert commentary surrounding biopharmaceuticals, biotechnology, bioprocessing and all topics related to pharma manufacturing. BioPharm International® is part of MultiMedia Healthcare, LLC.

 

CONTACT: Media Contacts

Theresa Burek / 609-250-4331

Michelle Wood / 609-716-7777

KEYWORD: UNITED STATES NORTH AMERICA NEW JERSEY

INDUSTRY KEYWORD: TECHNOLOGY MEDICAL DEVICES GENERAL HEALTH SCIENCE BIOTECHNOLOGY ALTERNATIVE MEDICINE HEALTH OTHER SCIENCE RESEARCH SOFTWARE PHARMACEUTICAL DATA MANAGEMENT

SOURCE: BioPharm International®

Copyright Business Wire 2019.

PUB: 07/11/2019 01:08 PM/DISC: 07/11/2019 01:08 PM

Copyright Business Wire 2019.

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

PLEASE BE ADVISED: Soon we will no longer integrate with Facebook for story comments. The commenting option is not going away, however, readers will need to register for a FREE site account to continue sharing their thoughts and feedback on stories. If you already have an account (i.e. current subscribers, posting in obituary guestbooks, for submitting community events), you may use that login, otherwise, you will be prompted to create a new account.

Load comments